Quick answer
Future Fund: Breakthrough is a £375m UK programme that co-invests in R&D-intensive UK companies raising at least £30m in a funding round led by private investors. It targets breakthrough technologies in life sciences, quantum, AI, clean tech and similar sectors. The programme operates on commercial terms and requires a qualifying lead investor.
Advisor summary
Future Fund: Breakthrough is a British Business Bank (via British Patient Capital) co-investment programme that invests alongside private investors into R&D-intensive UK companies raising larger growth rounds. The programme co-invests on the same terms as private investors and is aimed at companies developing transformative technologies.
Who this is for
R&D-intensive UK companies raising substantial growth rounds (typically £30m+) led by qualifying private investors.
Frequently asked questions
Who runs Future Fund: Breakthrough?
British Patient Capital, the subsidiary of the British Business Bank.
Does BPC set the terms?
No — BPC co-invests on the terms set by the qualifying lead investor.
What is the minimum round size?
The programme targets substantial growth rounds — refer to BPC's current criteria.
What sectors are eligible?
R&D-intensive sectors broadly — life sciences, deep-tech, quantum, AI, cleantech, materials.
How is R&D intensity measured?
By R&D spend as a share of operating costs and equivalent measures — refer to BPC guidance.
Are foreign-led rounds eligible?
Yes, provided the qualifying lead investor criteria are met and the company has UK operations.
Is there an application form?
Process runs through engagement with BPC — refer to their website.
How long does the process take?
Aligned to the private lead's timeline.
Are non-equity instruments funded?
Primarily equity co-investment.
Where is official guidance?
British Patient Capital's Future Fund: Breakthrough page.
Read end-to-end by a FundingAtlas editor against the official source.
Funding amount
Co-investment alongside private investors
Region
United Kingdom
Stage
Growth
Provider
British Business Bank — British Patient Capital
Advisor summary
Future Fund: Breakthrough is a British Business Bank (via British Patient Capital) co-investment programme that invests alongside private investors into R&D-intensive UK companies raising larger growth rounds. The programme co-invests on the same terms as private investors and is aimed at companies developing transformative technologies.
Key takeaways
- Co-investment
- R&D-intensive
- Larger rounds
- Private investor leadership
Who this is for
R&D-intensive UK companies raising substantial growth rounds (typically £30m+) led by qualifying private investors.
Real-world use cases
Deep-tech scale-up
Life sciences
Cleantech
What to prepare before applying
- 1
Lead investor
- 2
R&D evidence
- 3
Round structure
- 4
UK substance
Common mistakes
No lead investor
Insufficient R&D intensity
Wrong stage
Common rejection reasons
Out-of-scope sector or stage
Weak lead investor
Insufficient UK nexus
Alternative funding routes
British Patient Capital
Enterprise Capital Funds
Innovate UK Innovation Loans
BBB Investment Programme
Typical funding journey
- 1
Lead investor secures terms
- 2
BPC engagement
- 3
Co-investment decision
- 4
Round closes
Advisor view
This programme is an investor-side route — the rules govern your investors as much as your business. Treat it as a structuring decision, not a fundraising trick. Get advance assurance or the equivalent confirmation before issuing shares, and brief your investors and their accountants in writing. A clean cap table and matching share register are worth more than a polished pitch.
Usually too early when
Advisor signal
You have no incorporated UK trading entity, no draft cap table, no defined funding round, or you have already issued the shares you want covered.
Eligibility
UK-incorporated, R&D-intensive businesses raising £30m+ in a qualifying private round with a lead investor approved under the programme.
Common reasons applications fail
Issuing shares before getting advance assurance, breaching qualifying-trade rules, using the wrong share class, or running afoul of the connected-persons rules. Many failures are administrative rather than commercial.
What improves your odds
A tight one-page company summary, a clean cap table, and confirmation from an experienced accountant that you meet the qualifying-trade and gross-asset tests.
Typical successful applicant
A UK-incorporated company with a defined funding round, an experienced investor lead or fund manager, and an accountant familiar with HMRC advance assurance.
Common misconceptions
It is not free money — it is an investor relief or co-investment that makes your shares more attractive. It does not replace a fundable business model.
What comes next
After investment lands, file the compliance paperwork on time (SEIS1/EIS1 or fund manager equivalent), keep your share register tidy, and plan the next round before runway gets thin.
Funding context
Sits alongside the rest of the UK equity stack — angel, EIS, SEIS, VCT, growth-stage funds and patient capital. The right combination depends on round size, investor base and time horizon, not which scheme has the highest headline relief.
Eligibility Quick Check
A cautious, rules-based check using only the criteria already published for this programme. Not a guarantee — always verify against the official source.
Frequently asked questions
- Who runs Future Fund: Breakthrough?
- British Patient Capital, the subsidiary of the British Business Bank.
- Does BPC set the terms?
- No — BPC co-invests on the terms set by the qualifying lead investor.
- What is the minimum round size?
- The programme targets substantial growth rounds — refer to BPC's current criteria.
- What sectors are eligible?
- R&D-intensive sectors broadly — life sciences, deep-tech, quantum, AI, cleantech, materials.
- How is R&D intensity measured?
- By R&D spend as a share of operating costs and equivalent measures — refer to BPC guidance.
- Are foreign-led rounds eligible?
- Yes, provided the qualifying lead investor criteria are met and the company has UK operations.
- Is there an application form?
- Process runs through engagement with BPC — refer to their website.
- How long does the process take?
- Aligned to the private lead's timeline.
- Are non-equity instruments funded?
- Primarily equity co-investment.
- Where is official guidance?
- British Patient Capital's Future Fund: Breakthrough page.
Related routes
Industries
Objectives
Regions